Stage IIIB Colorectal Cancer Active Not Recruiting Phase 2 Trials for Regorafenib (DB08896)

IndicationStatusPhase
DBCOND0068494 (Stage IIIB Colorectal Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02368886Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerTreatment